Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Smith

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 9, 2016
Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test SitesKarol L Thompson, Eric Boitier, Tao Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 29, 2023
Impact of the physical-chemical properties of poly(lactic acid)-poly(ethylene glycol) polymeric nanoparticles on biodistributionMark J Jackman, Weimin Li, Aaron Smith, et al.
Journal of Medicinal Chemistry|June 16, 2026
Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent CancersSharan K Bagal, Coura R N Diène, Sandra Stefanovic-Barrett, et al.
The Journal of Organic Chemistry|June 14, 2021
A Stereocontrolled Synthesis of a Phosphorothioate Cyclic Dinucleotide-Based STING AgonistJames Kempson, Huiping Zhang, Xiaoping Hou, et al.
Journal of Medicinal Chemistry|September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal TumorsJason G Kettle, Rana Anjum, Evan Barry, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 7, 2017
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin studySyed Z Imam, Zhen He, Elvis Cuevas, et al.
Nature|February 6, 2023
Universal logic with encoded spin qubits in siliconAaron J Weinstein, Matthew D Reed, Aaron M Jones, et al.
Journal of Medicinal Chemistry|June 9, 2006
(2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesScott D Edmondson, Anthony Mastracchio, Robert J Mathvink, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating CancerMatthew T Burger, Sabina Pecchi, Allan Wagman, et al.
Nature Communications|November 9, 2019
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activityJacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 9, 2016
Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test SitesKarol L Thompson, Eric Boitier, Tao Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 29, 2023
Impact of the physical-chemical properties of poly(lactic acid)-poly(ethylene glycol) polymeric nanoparticles on biodistributionMark J Jackman, Weimin Li, Aaron Smith, et al.
Journal of Medicinal Chemistry|June 16, 2026
Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent CancersSharan K Bagal, Coura R N Diène, Sandra Stefanovic-Barrett, et al.
The Journal of Organic Chemistry|June 14, 2021
A Stereocontrolled Synthesis of a Phosphorothioate Cyclic Dinucleotide-Based STING AgonistJames Kempson, Huiping Zhang, Xiaoping Hou, et al.
Journal of Medicinal Chemistry|September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal TumorsJason G Kettle, Rana Anjum, Evan Barry, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 7, 2017
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin studySyed Z Imam, Zhen He, Elvis Cuevas, et al.
Nature|February 6, 2023
Universal logic with encoded spin qubits in siliconAaron J Weinstein, Matthew D Reed, Aaron M Jones, et al.
Journal of Medicinal Chemistry|June 9, 2006
(2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesScott D Edmondson, Anthony Mastracchio, Robert J Mathvink, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating CancerMatthew T Burger, Sabina Pecchi, Allan Wagman, et al.
Nature Communications|November 9, 2019
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activityJacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, et al.
Pageof 17